OLK
Olink Holding AB ADR
NASDAQ: OLK · HEALTHCARE · DIAGNOSTICS & RESEARCH
$26.08
+0.00% today
Updated 2026-04-30
Market cap
$3.24B
P/E ratio
—
P/S ratio
18.98x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Olink Holding AB ADR (OLK) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | $41.69M | $54.07M | $94.97M | $139.85M | $169.91M |
| Revenue growth (YoY) | — | +29.7% | +75.7% | +47.3% | +21.5% |
| Cost of revenue | $13.02M | $17.46M | $36.76M | $45.35M | $71.04M |
| Gross profit | $28.68M | $36.61M | $58.21M | $94.50M | $98.87M |
| Gross margin | 68.8% | 67.7% | 61.3% | 67.6% | 58.2% |
| R&D | $4.84M | $9.63M | $22.14M | $26.34M | $30.57M |
| SG&A | $26.61M | $20.10M | $47.49M | $54.27M | $105.79M |
| Operating income | $-10.66M | $-6.08M | $-44.65M | $-30.60M | $-49.94M |
| Operating margin | -25.6% | -11.3% | -47.0% | -21.9% | -29.4% |
| EBITDA | $-2.79M | $6.46M | $-30.57M | $-11.61M | $-30.91M |
| EBITDA margin | -6.7% | 11.9% | -32.2% | -8.3% | -18.2% |
| EBIT | $-10.66M | $-6.08M | $-44.65M | $-30.60M | $-49.94M |
| Interest expense | $6.60M | $6.63M | $2.05M | $531000.00 | $858000.00 |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.88M | $-6.78M | $-38.34M | $-12.85M | $-31.66M |
| Net income growth (YoY) | — | +62.1% | -465.5% | +66.5% | -146.3% |
| Profit margin | -42.9% | -12.5% | -40.4% | -9.2% | -18.6% |